Perrigo Price Target Increased to $174.00 by Analysts at Barrington Research (PRGO)
Analysts at Barrington Research hoisted their price objective on shares of Perrigo (NASDAQ:PRGO) from $142.00 to $174.00 in a research report issued to clients and investors on Monday, Stock Ratings Network.com reports. The firm currently has an “outperform” rating on the stock. Barrington Research’s target price indicates a potential upside of 21.06% from the stock’s previous close.
Other equities research analysts have also recently issued reports about the stock. Analysts at UBS AG raised their price target on shares of Perrigo from $140.00 to $160.00 in a research note to investors on Monday. They now have a “buy” rating on the stock. Separately, analysts at Stifel Nicolaus raised their price target on shares of Perrigo from $145.00 to $150.00 in a research note to investors on Friday. They now have a “buy” rating on the stock. Finally, analysts at JPMorgan Chase & Co. raised their price target on shares of Perrigo from $150.00 to $160.00 in a research note to investors on Friday. They now have an “overweight” rating on the stock. Six investment analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. Perrigo has a consensus rating of “Buy” and an average price target of $138.27.
Shares of Perrigo (NASDAQ:PRGO) traded up 0.95% on Monday, hitting $143.73. 1,327,145 shares of the company’s stock traded hands. Perrigo has a 52-week low of $98.79 and a 52-week high of $142.58. The stock has a 50-day moving average of $128.3 and a 200-day moving average of $123.3. The company has a market cap of $13.554 billion and a P/E ratio of 30.04.
Perrigo (NASDAQ:PRGO) last posted its quarterly earnings results on Thursday, October 31st. The company reported $1.52 earnings per share for the quarter, beating the analysts’ consensus estimate of $1.40 by $0.12. The company had revenue of $933.00 million for the quarter, compared to the consensus estimate of $900.10 million. During the same quarter last year, the company posted $1.27 earnings per share. Perrigo’s revenue was up 21.3% compared to the same quarter last year. On average, analysts predict that Perrigo will post $6.57 earnings per share for the current fiscal year.
Perrigo Company is a global healthcare supplier that develops, manufactures and distributes over-the-counter (NASDAQ:PRGO) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products and active pharmaceutical ingredients (API).
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.